Skip to main content
Log in

Up-regulation of expression of translation factors – a novel molecular mechanism for cadmium carcinogenesis

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

The molecular mechanisms potentially responsible for cadmium carcinogenesis were investigated by differential gene expression analysis of Balb/c-3T3 cells morphologically transformed with cadmium chloride. Differential display analysis of gene expression revealed overexpression of mouse Translation Initiation Factor 3 (TIF3; GenBank Accession Number AF 271072) and Translation Elongation Factor-1δ (TEF-1δ; GenBank Accession Number AF 304351) in the transformed cells compared with the control cells. The full length cDNAs for TIF3 and TEF-1δ were cloned and sequenced. Transfection of mammalian cells with an expression vector containing either TIF3 or TEF-1δ cDNA resulted in overexpression of the encoded protein. Overexpression of the cDNA-encoded TIF3 and TEF-1δ proteins in NIH3T3 cells was oncogenic as evidenced by the appearance of transformed foci capable of anchorage-independent growth on soft agar and tumorigenesis in nude mouse. Blocking the translation of TIF3 and TEF-1δ proteins using the corresponding antisense mRNA resulted in a significant reversal of the oncogenic potential of cadmium transformed Balb/c-3T3 cells as evidenced from the suppression of anchorage-independent growth on soft agar and diminished tumorigenesis in nude mouse. These findings demonstrate that the up-regulation of expression of TIF3 and TEF-1δ is a novel molecular mechanism responsible, at least in part, for cadmium carcinogenesis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. International Agency for Research on Cancer: Beryllium, cadmium, mercury and exposures in glass manufacturing industry. Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 58. International Agency for Research on Cancer, Lyon, France, 1993, pp 403–420

    Google Scholar 

  2. Thun MJ, Elinder C-G, Friberg L: Scientific basis for an occupational standard for cadmium. Am J Ind Med 20: 629–642, 1991

    Google Scholar 

  3. Waalkes MP, Coogan TP, Barter RA: Toxicological principles of metal carcinogenesis with special emphasis on cadmium. Crit Rev Toxicol 22: 175–201, 1992

    Google Scholar 

  4. Waalkes MP: Cadmium carcinogenesis in review. J Inorg Biochem 79: 241–244, 2000

    Google Scholar 

  5. Snow ET: Metal carcinogenesis: Mechanistic implications. Pharmacol Ther 53: 31–65, 1992

    Google Scholar 

  6. Joseph P, Lei YX, Whong WZ, Ong TM: Oncogenic potential of mouse translation elongation factor-1δ, a novel cadmium-responsive proto-oncogene. J Biol Chem 277: 6131–6136, 2002

    Google Scholar 

  7. Joseph P, Lei YX, Whong WZ, Ong TM: Molecular cloning and functional analysis of a novel cadmium-responsive proto-oncogene. Cancer Res 62: 703–707, 2002

    Google Scholar 

  8. Lei Y-X, Joseph P, Ong TM: Antisense inhibition of translation initiation factor 3 reverses its oncogenic potential. Teratogen Carcinogen Mutagen 22: 403–409, 2002

    Google Scholar 

  9. Barrett JC, Hesterberg TW, Thomassen DG: Use of cell transformation system for carcinogenicity testing and mechanistic studies of carcinogens. Pharmacol Rev 36: 53S–70S, 1984

    Google Scholar 

  10. Keshava N, Zhou G, Hubbs AF, Ensell M-X, Ong TM: Transforming and carcinogenic potential of cadmium chloride in BALB/c-3T3 cells. Mutat Res 448: 23–28, 2000

    Google Scholar 

  11. Land H, Parada LF, Weinberg RA: Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596–602, 1983

    Google Scholar 

  12. Anand N, Murthy S, Amann G, Wernick M, Porter LA, Cukier IH, Collins C, Gray JW, Diebold J, Demetrick DJ, Lee JM: Gene encoding protein elongation factor EEF1A2 is a putative oncogene in ovarian cancer. Nat Genet 31: 301–305, 2002

    Google Scholar 

  13. Matsuoka M, Call KM: Cadmium-induced expression of immediate early genes in LLC-PK1 cells. Kidney Int 48: 383–389, 1995

    Google Scholar 

  14. Joseph P, Muchnok TK, Klishis ML, Roberts JR, Antonini JM, Whong W-Z, Ong TM: Cadmium-induced cell transformation and tumorigenesis are associated with transcriptional activation of c-fos, c-jun and c-myc proto-oncogenes: Role of cellular calcium and reactive oxygen species. Toxicol Sci 61: 295–303, 2001

    Google Scholar 

  15. Palmiter R.D: Molecular biology of metallothionein gene expression. In: H.R. Kagi, Y. Kojima (eds). Metallothionein II. Burkhauser Verlag, Basel, 1987, pp 63–80.

    Google Scholar 

  16. Abe T, Yamamoto O, Gotoh S, Yan Y, Todaka, N, Higashi K: Cadmium-induced mRNA expression of Hsp32 is augmented in metallothionein-I and-II knock-out mice. Arch Biochem Biophys 382: 81–88, 2000

    Google Scholar 

  17. Liu J, Kadiiska MB, Corton C, Qu W, Waalkes MP, Mason RP, Liu Y, Klaassen CD: Acute cadmium exposure induces stress-related gene expression in wild-type and metallothionein-I/II-null mice. Free Radical Biol Med 32: 525–535, 2002

    Google Scholar 

  18. Chin TA, Templeton DM: Protective elevations of glutathione and metallothionein in cadmium-exposed mesangial cells. Toxicology 77: 145–156, 1993

    Google Scholar 

  19. Eneman JD, Potts RJ, Osier M, Shukla GS, Lee CH, Chiu J-F, Hart BA: Suppressed oxidant-induced apoptosis in cadmium-adapted alveolar epithelial cells and its potential involvement in cadmium carcinogenesis. Toxicology 147: 215–228, 2000

    Google Scholar 

  20. Shukla GS, Hussain T, Srivatsava RS, Chandra SV: Glutathione peroxidase and catalase in liver, kidney, testis and brain regions of rats following cadmium exposure and subsequent withdrawal. Ind Health 27: 59–69, 1989

    Google Scholar 

  21. Li Q, Hu N, Daggett MA, Chu WA, Bittel D, Johnson JA, Andrews GK: Participation of upstream stimulator factor (USF) in cadmium-induction of the mouse metallothionein-I gene. Nucleic Acids Res 26: 5182–5189, 1998

    Google Scholar 

  22. Andrews GK: Regulation of metallothionein gene expression by oxidative stress and metal ions. Biochem Pharmacol 59: 95–104, 2000

    Google Scholar 

  23. Alam J, Wicks C, Stewart D, Gong P, Touchard C, Otterbein S, Choi AMK, Burow ME, Tou J: Mechanism of heme oxygenase-1 gene activation by cadmium in MCF-7 mammary epithelial cells. J Biol Chem 275: 27694–27702, 2000

    Google Scholar 

  24. Thevenod F, Friedman JM, Katsen AD, Hauser IA: Up-regulation of multidrug resistance p-glycoprotein via nuclear-factor kappa B activation protects kidney proximal tubule cells from cadmium and reactive oxygen species-induced apoptosis. J Biol Chem 275: 1887–1896, 2000

    Google Scholar 

  25. Liao VH, Freedman JH: Cadmium-regulated genes from the nematode Caenorhabditis elegans. Identification and cloning of new cadmium-responsive genes by differential display. J Biol Chem 273: 31962–31970, 1998

    Google Scholar 

  26. Momose Y, Iwahashi H: Bioassay of cadmium using a DNA microarray: Genome-wide expression patterns of Saccharomyces cerevisiae in response to cadmium. Environ Toxicol Chem 20: 2353–2360, 2001

    Google Scholar 

  27. Yamada H, Koizumi S: DNA microarray analysis of human gene expression induced by a non-lethal dose of cadmium. Ind Health 40: 159–166, 2002

    Google Scholar 

  28. Riis B, Rattan SIS, Clark BFC, Merrick WC: Eukaryotic translation elongation factors. TIBS 15: 420–424, 1990

    Google Scholar 

  29. Sonenberg N: Translation factors as effectors of cell growth and tumorigenesis. Curr Opin Cell Biol 5: 955–960, 1993

    Google Scholar 

  30. Sonenberg N: Regulation of translation and cell growth by eIF4E. Biochimie 76: 839–846, 1994

    Google Scholar 

  31. Zimmer SG, DeBenedetti A, Graff JR: Translational control of malignancy: The mRNA cap-binding protein, eIF-4E, as a central regulator of tumor promotion, growth, invasion and metastasis. Anticancer Res 20: 1343–1352, 2000.

    Google Scholar 

  32. Tatsuka M, Mitsui M, Wada A, Nagata H, Nojima H, Okayama H: Elongation factor-1 alpha gene determines susceptibility to transformation. Nature 359: 333–336, 1992

    Google Scholar 

  33. Chi K, Jones DV, Frazier ML: Expression of an elongation factor 1 gamma-related sequence in adenocarcinomas of the colon. Gastroenterology 103: 98–102, 1992

    Google Scholar 

  34. Grant AG, Flomen RM, Tizard MLV, Grant DAW: Differential screening of a human pancreatic adenocarcinoma lambda gt11 expression library has identified increased transcription of elongation factor EF-1alpha in tumor cells. Int J Cancer 51: 740–745, 1992

    Google Scholar 

  35. Lew Y, Jones DV, Mars WM, Evans D, Byrd D, Frazier ML: Expression of elongation factor-1 gamma-related sequence in human pancreatic cancer. Pancreas 7: 144–152, 1992

    Google Scholar 

  36. Ender B, Lynch P, Kim YH, Inamdar NV, Cleary KR, Frazier ML: Overexpression of an elongation factor-1 gamma hybridizing RNA in colorectal adenomas. Mol Carcinogenesis 7: 18–20, 1993

    Google Scholar 

  37. Sanders J, Raggiaschi R, Morales J, Moller W: The human leucine zipper-containing guanine-nucleotide exchange protein elongation factor-1 delta. Biochim Biophys Acta 1174: 87–90, 1993

    Google Scholar 

  38. Kerekatte V, Smiley K, Hu B, Smith A, Gelder F, De Benedetti A: The proto-oncogene/translation factor eIF4E: A survey of its expression in breast carcinomas. Int J Cancer 64: 27–31, 1995

    Google Scholar 

  39. Miyagi Y, Sugiyama A, Asai A, Okazaki T, Kuchino Y, Kerr SJ: Elevated levels of eukaryotic translation factor eIF4E mRNA in a broad spectrum of transformed cell lines. Cancer Lett 91: 247–252, 1995

    Google Scholar 

  40. Shen R, Su Z-Z, Olsson CA, Fisher PB: Identification of the human prostatic carcinoma oncogene PTI-1 by rapid expression cloning and differential RNA display. Proc Natl Acad Sci USA 92: 6778–6782, 1995

    Google Scholar 

  41. Eberle J, Krasagakis K, Orfanos CE: Translation initiation factor eIF4A1 mRNA is consistently overexpressed in human melanoma cells in vitro. Int J Cancer, 71: 396–401, 1997

    Google Scholar 

  42. De Benedetti A, Harris AL: eIF4E expression in tumors: Its possible role in progression of malignancies. Int J Biochem Cell Biol 31: 59–72, 1999

    Google Scholar 

  43. Shuda M, Kondoh N, Tanaka K, Ryo A, Wakatsuki T, Hada A, Goseki N, Igari T, Hatsuse K, Aihara T, Horiuchi S, Shichita M, Yamamoto N, Yamamoto M: Enhanced expression of translation factor mRNAs in hepatocellular carcinoma. Anticancer Res 20: 2489–2494, 2000

    Google Scholar 

  44. Song JM, Picologlou S, Grant CM, Firoozan M, Tuite MF, Liebamn S: Elongation factor EF-1 alpha gene dosage alters translational fidelity in Saccharomyces cerevisiae. Mol Cell Biol 9: 4571–4575, 1989

    Google Scholar 

  45. Carr-Schmid A, Durko N, Cavallius J, Merrick WC, Kinzy TG: Mutations in a GTP-binding motif of eukaryotic elongation factor 1A reduce both translational fidelity and the requirement for nucleotide exchange. J Biol Chem 274: 30297–30302, 1999

    Google Scholar 

  46. Cavallius J, Rattan SIS, Clark BFC: Changes in activity and amount of active elongation factor 1 alpha in aging and immortal human fibroblast cultures. Exp Gerontol 21: 149–157, 1986

    Google Scholar 

  47. Sheperd JCW, Waldorf U, Hug P, Gehring WJ: Fruit flies with additional expression of the elongation factor EF-1 alpha live longer. Proc Natl Acad Sci USA 86: 7520–7521, 1989

    Google Scholar 

  48. Gopalakrishnan RV, Su Z-Z, Goldstein NI, Fisher PB: Translational infidelity and human cancer: Role of the PTI-1 oncogene. Int J Biochem Cell Biol 31: 151–162, 1999

    Google Scholar 

  49. Edmonds BT, Wyckoff J, Yeung YG, Wang Y, Stanly ER, Jones J, Segall J, Condeelis J: Elongation factor-1 alpha is an overexpressed actin binding protein in metastatic rat mammary adenocarcinoma. J Cell Sci 109: 2705–2714, 1986

    Google Scholar 

  50. Rosenwald IB, Karatzas N, Sonenberg N, Schmidt EV: Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor eIF4E. Mol Cell Biol 13: 7358–7363, 1993

    Google Scholar 

  51. Rousseau D, Kasper R, Rosenwald I, Gehrke L, Sonenberg M: Translation initiation of ornithine decarboxylase and nucleocytoplasmic transport of cyclin D1 mRNA are increased in cells overexpressing eukaryotic initiation factor 4E. Proc Natl Acad Sci USA 93: 1065–1070, 1996

    Google Scholar 

  52. Lazaris-Karatzas A, Smith MR, Frederickson RM, Jaramillo ML, Liu YL, Kung HF, Sonenberg N: Ras mediates translation initiation factor-induced malignant transformation. Genes Dev 6: 1631–164, 1992

    Google Scholar 

  53. Saito H, Hayday AC, Wiman K, Hayward WS, Tonegawa S: Activation of the c-myc gene by translocation: A model for translational control. Proc Natl Acad Sci USA 80: 7476–7480, 1983

    Google Scholar 

  54. De Benedetti A, Joshi B, Graff JR, Zimmer SG: CHO cells transformed by the translation factor eIF4E display increased c-myc expression, but require overexpression of Max for tumorigenicity. Mol Cell Diff 2: 347–371, 1994

    Google Scholar 

  55. Flynn A, Proud CG: The role of eIF4E in cell proliferation. Cancer Surveys 27: 293–310, 1996

    Google Scholar 

  56. Rhoads RE: Protein synthesis, cell growth and oncogenesis. Curr Opin Cell Biol 3: 1019–1024, 1991

    Google Scholar 

  57. Rosenwald IB: Deregulation of protein synthesis as a mechanism of neoplastic transformation. Bioessays 18: 77–82, 1996

    Google Scholar 

  58. Fakuchi-Shimogori T, Ishii I, Kashiwagi K, Mashiba H, Ekimoto H, Igarashi K: Malignant transformation by overproduction of translation initiation factor eIF4G. Cancer Res 57: 5041–5044, 1997

    Google Scholar 

  59. Clemens MJ, Bommer UA: Translational control: The cancer connection. Int J Biochem Cell Biol 31: 1–23, 1999

    Google Scholar 

  60. Misra UK, Gawdi G, Akabani G, Pizzo SV: Cadmium-induced DNA synthesis and cell proliferation in macrophages: The role of intracellular calcium and signal transduction mechanisms. Cell Signal 14: 327–340, 2002

    Google Scholar 

  61. Lee SA, Dritschilo A, Jung M: Role of ATM in oxidative stress-mediated c-jun phosphorylation in response to ionizing radiation and CdCl2. J Biol Chem 276: 11783–11790, 2001

    Google Scholar 

  62. Rinker-Schaeffer CW, Graff JR, De Benedetti A, Zimmer SG, Rhoads RE: Decreasing the level of translation initiation factor 4E with antisense RNA causes reversal of ras-mediated transformation and tumorigenesis of cloned rat embryo fibroblasts. Int J Cancer 55: 841–847, 1993

    Google Scholar 

  63. Shantz LM, Pegg AE: Overproduction of ornithine decarboxylase caused by relief of translational repression is associated with neoplastic transformation. Cancer Res 54: 2313–2316, 1996

    Google Scholar 

  64. Su Z, Goldstein NI, Fisher PB: Antisense inhibition of the PTI-1 oncogene reverses cancer phenotypes. Proc Natl Acad Sci USA 95: 1764–1769, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Joseph, P., Lei, YX. & Ong, Tm. Up-regulation of expression of translation factors – a novel molecular mechanism for cadmium carcinogenesis. Mol Cell Biochem 255, 93–101 (2004). https://doi.org/10.1023/B:MCBI.0000007265.38475.f7

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:MCBI.0000007265.38475.f7

Navigation